Concepedia

Paul V. Beum

PV

20

Publications

2K

Citations

18

H-Index

1999

Active since

Affiliations

University of Virginia(Current)

Genmab (Netherlands)

University Medical Center Utrecht

University of Nebraska Medical Center

Genmab (United States)

Paul V. Beum is an author at University of Virginia specializing in cell biology, immunology, and medicine.

Top concepts

Publications per year

1999–2014

20

Publications

20

Rituximab Infusion Promotes Rapid Complement Depletion and Acute CD20 Loss in Chronic Lymphocytic Leukemia

Adam D. Kennedy, Paul V. Beum, Michael D. Solga et al. · The Journal of Immunology · 2004 · 351 citations · Full text

Binding of Submaximal C1q Promotes Complement-Dependent Cytotoxicity (CDC) of B Cells Opsonized with Anti-CD20 mAbs Ofatumumab (OFA) or Rituximab (RTX): Considerably Higher Levels of CDC Are Induced by OFA than by RTX

Andrew W. Pawluczkowycz, Frank J. Beurskens, Paul V. Beum et al. · The Journal of Immunology · 2009 · 254 citations · Full text

, , +18

The Shaving Reaction: Rituximab/CD20 Complexes Are Removed from Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Cells by THP-1 Monocytes

Paul V. Beum, Adam D. Kennedy, Michael E. Williams et al. · The Journal of Immunology · 2006 · 225 citations · Full text

Thrice-Weekly Low-Dose Rituximab Decreases CD20 Loss via Shaving and Promotes Enhanced Targeting in Chronic Lymphocytic Leukemia

Michael E. Williams, John Densmore, Andrew W. Pawluczkowycz et al. · The Journal of Immunology · 2006 · 148 citations · Full text

, , +17

Loss of CD20 and Bound CD20 Antibody from Opsonized B Cells Occurs More Rapidly Because of Trogocytosis Mediated by Fc Receptor-Expressing Effector Cells Than Direct Internalization by the B Cells

Paul V. Beum, Elizabeth M. Peek, Margaret A. Lindorfer et al. · The Journal of Immunology · 2011 · 137 citations · Full text

, , +26

Rows per page

1–5 of 20